XTL Biopharmaceuticals Ltd.
XTLBNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $1.72M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.70$5.64
- Volume (live)
- -
- Avg. volume (3M)
- 6.98K
XTL Biopharmaceuticals (XTLB) Stock Price & Financial Analysis
XTL Biopharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.78 - $1.97 |
|---|---|
| 52-Week High | $5.64 |
| 52-Week Low | $0.70 |
| Open | $1.86 |
| Volume (last close) | 10.36K |
| Average Volume (3M) | 6.98K |
| 50-Day MA | $2.38 |
|---|---|
| 200-Day MA | $2.75 |
| 1-Year Change | +58.87% |
| Market Cap | 1.72M |
|---|---|
| Shares Outstanding | 871.35K |
| Price to Book (P/B) | -6.76 |
| EV/EBITDA | 1.19 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
XTL Biopharmaceuticals at a Glance
As of the Oct 22, 2026 close, XTL Biopharmaceuticals (XTLB) has a market capitalization of $1.72M. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $76.00K in cash and securities against $269.00K of debt, a net debt position of $193.00K.
XTL Biopharmaceuticals does not currently pay a dividend.
The share price is up 58.9% over the past year. At $1.97 (the Oct 22, 2026 close) it sits within its 52-week range of $0.70 to $5.64, below its 200-day moving average of $2.75.
Frequently Asked Questions About XTL Biopharmaceuticals
What is the current stock price for XTLB?
As of the Oct 22, 2026 close, XTLB stock trades at $1.97. The 52-week range is $0.70–$5.64, with a day range of $1.78–$1.97.
What is the P/E ratio for XTLB?
The P/E ratio (Price-to-Earnings) for XTLB is shown in the Key Statistics section. This valuation metric helps compare XTL Biopharmaceuticals Ltd. to industry peers.
Does XTLB pay dividends?
XTL Biopharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for XTLB?
Analyst ratings and recommendations for XTLB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of XTLB?
As of the Oct 22, 2026 close, XTL Biopharmaceuticals's market capitalization is $1.7M, classifying it as a micro-cap company. XTL Biopharmaceuticals operates in the Healthcare sector within the Biotechnology industry.